Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Merck
Merck
Page 3 of 9
Health
Merck says its breakthrough COVID-19 pill doesn’t work nearly as well as previously reported
By
Fiona Rutherford
and
Bloomberg
November 26, 2021
Health
Merck says the U.S. will buy 1.4 million doses of its COVID-19 antiviral pill
By
John Lauerman
and
Bloomberg
November 9, 2021
Health
Pfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward
By
David Meyer
November 5, 2021
Health
Merck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
By
Frank Connelly
and
Bloomberg
November 4, 2021
Health
Merck says poorer countries can produce its new COVID pill without paying royalties
By
David Meyer
October 27, 2021
Health
Rich countries’ rush to buy Merck antiviral pill risks leaving poor countries behind in COVID fight—again
By
James Paton
and
Bloomberg
October 12, 2021
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By
Matthew Perrone
and
The Associated Press
October 11, 2021
Health
Merck’s breakthrough COVID pill faces a risk: the virus could outsmart it
By
Thomas Mulier
,
Riley Griffin
and
Bloomberg
October 8, 2021
Health
Everything to know about Merck’s COVID antiviral pill
By
Emily Mullin
October 5, 2021
Health
Shares of vaccine makers slump as Merck unveils data from its ‘game-changer’ COVID pill
By
Abhishek Vishnoi
and
Bloomberg
October 4, 2021
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By
Matthew Perrone
and
The Associated Press
October 1, 2021
Health
The psychology behind why people will take horse paste, but not COVID vaccines
By
Sy Mukherjee
September 2, 2021
Health
Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world
By
Sophie Mellor
September 2, 2021
Health
Booster shots and a big jump in market value: 3 takeaways from Moderna’s Q2 earnings
By
Sy Mukherjee
August 5, 2021
Tech
IBM, Merck and OneTen launch network to recruit and promote Black workers over the next decade
By
Jeff Green
and
Bloomberg
June 29, 2021
Most Popular
Personal Finance
Peter Thiel makes his biggest donation in years to help defeat California’s billionaire wealth tax
By
Nick Lichtenberg
Europe
Americans have been quietly plundering Greenland for over 100 years, since a Navy officer chipped fragments off the...
By
Paul Bierman
and
The Conversation
Health
The head of marketing at Slate posted on LinkedIn requesting cleaning services as a benefit at her company. The next...
By
Sydney Lake